The mammalian heart has a remarkable regenerative capacity for a short period of time after birth, after which the majority of cardiomyocytes permanently exit cell cycle. We sought to determine the primary postnatal event that results in cardiomyocyte cell-cycle arrest. We hypothesized that transition to the oxygen-rich postnatal environment is the upstream signal that results in cell-cycle arrest of cardiomyocytes. Here, we show that reactive oxygen species (ROS), oxidative DNA damage, and DNA damage response (DDR) markers significantly increase in the heart during the first postnatal week. Intriguingly, postnatal hypoxemia, ROS scavenging, or inhibition of DDR all prolong the postnatal proliferative window of cardiomyocytes, whereas hyperoxemia and ROS generators shorten it. These findings uncover a protective mechanism that mediates cardiomyocyte cell-cycle arrest in exchange for utilization of oxygen-dependent aerobic metabolism. Reduction of mitochondrial-dependent oxidative stress should be an important component of cardiomyocyte proliferation-based therapeutic approaches.
INTRODUCTION
The pathophysiological basis of heart failure is the inability of the adult heart to regenerate lost or damaged myocardium, and although limited myocyte turnover does occur in the adult heart, it is insufficient for restoration of contractile dysfunction (Bergmann et al., 2009; Hsieh et al., 2007; Laflamme et al., 2002; Nadal-Ginard, 2001; Quaini et al., 2002) . In contrast, the neonatal mammalian heart is capable of substantial regeneration following injury through cardiomyocyte proliferation (Porrello et al., 2011b , not unlike urodele amphibians (Becker et al., 1974; Flink, 2002; Oberpriller and Oberpriller, 1974) or teleost fish (Gonzá lez-Rosa et al., 2011; Poss et al., 2002; Wang et al., 2011) . However, this regenerative capacity is lost by postnatal day 7 (Porrello et al., 2011b , which coincides with cardiomyocyte binucleation and cell-cycle arrest (Soonpaa et al., 1996) . Although several regulators of cardiomyocytes cell cycle postnatally have been identified (Bersell et al., 2009; Chen et al., 2013; Eulalio et al., 2012; Mahmoud et al., 2013; Porrello et al., 2011a; Sdek et al., 2011; Xin et al., 2013) , the upstream signal that causes permanent cell-cycle arrest of most cardiomyocytes remains unknown.
One of many factors shared by organisms that are capable of heart regeneration is the oxygenation state. For example, the zebrafish's stagnant and warm aquatic environment has 1/30 th oxygen capacitance compared to air and is prone to poor oxygenation, which may explain the remarkable tolerance of Relative mtDNA content in adult zebrafish was even smaller than that in P1 mouse.
(C) TEM images of ventricles showed more mature cristae structure in P7 mouse heart comparing with P1 mouse heart and adult zebrafish heart (left). The number of mitochondrial cristae counted from SEM images increased in P7 mouse heart compared to P1 mouse heart (table, blue bars) and also to adult zebrafish heart (table, red bar).
(D) HPLC detection of a superoxide probe dihydroethidium (DHE) revealed a significant increase in both 2-hydroxyethidium (EOH), a specific product for superoxide anion radical, and in ethidium (E), oxidized by other reactive oxygen species such as H 2 O 2 (mainly) and ONOO from P1 to P7.
(E) Imaging of ROS on cryosections with dihydrorhodamine 123 staining indicated linear increase in cardiomyocyte ROS level from P1 to P7 (arrows).
(F) Immunostaining with oxidative DNA damage and DNA damage response (DDR) markers. A marker for oxidative base modification in DNA, 8-oxo-7,8-dihydroguanine (8-oxoG, left panels), and for activation of DDR, Ser1987 phosphorylated ATM (pATM, right panels) were not detected in cardiomyocyte nuclei at P1 (legend continued on next page) zebrafish to hypoxia (Rees et al., 2001; Roesner et al., 2006) . Typical air-saturated water has a PaO 2 of 146 mm Hg and zebrafish can tolerate hypoxia at PaO 2 of 15 mm Hg (10% air-saturation) for 48 hr and even 8 mm Hg with hypoxic preconditioning. Moreover, the zebrafish circulatory system is relatively hypoxemic, as it has a primitive two-chamber heart with one atrium and one ventricle, which results in mixing of arterial and venous blood.
The mammalian heart has four chambers with no mixing of arterial and venous blood; however, during intrauterine life, the mammalian fetal circulation is shunt-dependent with significant arteriovenous mixing of arterial and venous blood. Mixing and shunting of blood occurs at three sites: the ductus venosus, foramen ovale, and ductus arteriosus. Blood in the umbilical vein going to the fetus is 80%-90% saturated with a PaO 2 of 32-35 mm Hg whereas the fetal venous blood return is quite desaturated at 25%-40%. Despite preferential streaming of blood through the shunts to preserve the most oxygenated blood for the brain and the myocardium, the saturation of the blood ejected from the left ventricle is only 65% saturated with a PaO 2 of 25-28 mm Hg (Dawes et al., 1954) . Therefore, both the zebrafish heart and the mammalian fetal heart reside in relatively hypoxic environments ( Figure 1A) .
Transition from embryonic-to postnatal circulation soon after birth drastically changes the oxygenation state of cardiomyocytes. For example, arterial pO 2 increases from 30 mm Hg (Lawrence et al., 2008; Mitchell and Van Kainen, 1992; Reynolds et al., 1996) to 100 mm Hg (Webster and Abela, 2007) (Figure 1A ). In parallel, energy metabolism of the embryonic and adult heart is quite distinct. During embryonic development, when cardiomyocytes rapidly proliferate, the relatively hypoxic embryonic heart utilizes anaerobic glycolysis as a main source of energy (Fisher et al., 1980; Lopaschuk et al., 1992) , whereas adult cardiomyocytes utilize the oxygen-dependent mitochondrial oxidative phosphorylation as an energy source (Gertz et al., 1988; Wisneski et al., 1985) . Nevertheless, the time frame of this metabolic shift and its relation to cardiomyocyte cell cycle is unknown.
Mitochondrial oxidative phosphorylation produces 18 times as much ATP as cytoplasmic glycolysis (Dismukes et al., 2001; Semenza, 2007) . However, the energy advantage of mitochondrial oxidative phosphorylation over glycolysis is not without deleterious consequences, as the mitochondrion is considered the major source of free radical production (Miquel et al., 1980; Turrens, 1997 Turrens, , 2003 . Mitochondrial ROS are generated as a consequence of electron leak by the electron transport chain (Koopman et al., 2010; Rudolph and Heyman, 1974) and can cause cellular toxicity by promoting damage of proteins, nucleic acids, lipids, or DNA, such as oxidized base, single-or double-strand breaks, resulting in cell-cycle arrest, apoptosis, or cellular senescence (Hoeijmakers, 2009; Marnett et al., 2003; Moos et al., 2000) . The role of mitochondrial ROS or DNA damage response in postnatal cell-cycle arrest of cardiomyocytes is unknown.
Here, we show that early postnatal mouse and zebrafish hearts share a low mitochondrial content and complexity and lack markers of DNA damage response, all of which significantly increase in the postnatal mouse heart within days after birth. Moreover, we show that there is a temporal shift from glycolytic to oxidative metabolism, with a subsequent increase in mitochondrial ROS production, which induces cardiomyocyte cellcycle arrest through activation of the DNA damage response. Systemic scavenging of ROS, specific scavenging of mitochondrial ROS in cardiomyocytes, or inhibition of the DNA damage response pathway all delay postnatal cell-cycle arrest of cardiomyocytes. These findings identify ROS-induced activation of the DNA damage response pathway as an important mediator of cell-cycle arrest in postnatal cardiomyocytes.
RESULTS

Mitochondrial Characteristics in Neonatal and Zebrafish Hearts
In order to examine the relationship between mitochondrial respiration and regenerative potential in vertebrate hearts amongst species, we first examined mitochondrial DNA content in the ventricular chamber of the heart with quantitative RT-PCR (qRT-PCR) (primers are indicated in Table S1 ) over 2 weeks after birth in mouse (n = 3) and adult zebrafish (n = 3). Mitochondrial DNA copy number showed a linear increase in the first 2 weeks after birth ( Figure 1B , blue bars). Intriguingly, mitochondrial DNA per gram of tissue was low in adult zebrafish and early neonatal mouse hearts ( Figure 1B ) compared to in the hearts of later postnatal age mice. Next, we examined mitochondrial cristae density, an index of increased proton pumping capacity of mitochondria, in adult zebrafish heart (n = 3) and neonatal mouse hearts (n = 3), using transmission electron microscopy (TEM) imaging. Mitochondrial cristae were sparse in zebrafish and P1 mouse in ventricular cardiomyocytes, but became dense and well-organized at P7 and later postnatal time points ( Figure 1C ).
To further assess capacity of oxidative metabolism in the postnatal mouse heart, we performed comprehensive mass spectrometry-based quantification of enzymes involved in both aerobic and anaerobic metabolism. We found that the majority of the enzymes related to glycolysis were downregulated from P1 to P7, and concomitantly, the majority of the enzymes involved in mitochondrial Krebs cycle were upregulated in the same time frame (Figure S1A available online). Importantly, over 80% of fatty acid beta oxidation enzymes, the main source of energy in mature cardiomyocytes (Lopaschuk et al., 1994) , were upregulated from P1 to P7 ( Figure S1A ). Finally, we measured mitochondrial NADH oxidase activity, a direct measure of NADH flux through mitochondrial electron transport chain enzymes, and found a significant increase in the same time frame, from P1 to P7 ( Figure S1B ). These results demonstrate that a precise correlation exists between the regenerative (top panels, white arrows), whereas at P7 (middle panels) and at P14 (lower panels) both 8-oxoG and pATM showed nuclear localization (colocalized with Hoechst 33258, Ho) indicated by arrows. (G) Oxidative DNA damage and DDR were induced before P7 in cardiomyocyte. Left panels: representative images of 3D imaging of 8-oxoG staining and the number of 8-oxoG foci per cardiomyocyte. Right panels: western blot and quantification of pATM indicating upregulation of DDR. Cardiac troponin T (TnT) was used to normalize sample loading. Error bars represent SEM. *p < 0.05; **p < 0.01. (B) Oxidative DNA damage indicated by nuclear signal with anti-8-oxoG antibody in cardiomyocyte was increased in hyperoxic hearts (left panels) and decreased in hypoxic hearts (right panels). (C) Heart weight versus body weight (HW/BW) ratio showed no statistically significant difference in mice exposed to hyperoxia, whereas significantly increased in mice exposed to hypoxia. (D) Cardiomyocyte cell size did not show significant difference in hyperoxia and was decreased in hypoxia.
(legend continued on next page) zebrafish heart and the early neonatal mouse heart and outline the time frame of the metabolic switch from anaerobic glycolysis to mitochondrial oxidative phosphorylation in mouse heart within one week after birth.
Activation of DNA Damage Response Pathway in Postnatal Mouse Heart An important byproduct of mitochondrial respiration is the generation of reactive oxygen species (ROS), which cause cellular oxidative stress, in turn inducing various types of cellular toxicity including widespread damage to proteins, lipids, and nucleic acids (Judge and Leeuwenburgh, 2007) . We therefore assessed the production of ROS and oxidative stress in postnatal cardiomyocytes. ROS were measured by the detection of dihydroethidium (DHE) oxidation product 2-hydroxyethidine (EOH), which is a marker of superoxide generation, and ethidium (E), which is a marker of hydrogen peroxide (H 2 O 2 ) primarily and other ROS, with high-performance liquid chromatography (HPLC) ( Figure 1D ) (Zhao et al., 2005) . In addition, the fluorescence of ROS indicator dihydrorhodamine 123 ( Figure 1E ), as well as 2 0 ,7 0 -dichlorofluorescein (H2DCF) ( Figure S1C ) (Mills et al., 1998; Sundaresan et al., 1995) , further supported the increased ROS levels in cardiomyocytes after birth. Moreover, we found that reduced glutathione (L-g-glutamyl-L-cysteinylglycine [GSH] ) and oxidized glutathione disulfide (GSSG) both decreased progressively from P1 to P4 and further at P7 ( Figure S1D ). However, GSSG decreased to a greater extent, which resulted in an overall increase in the GSH:GSSH ratio ( Figure S1D ). Although the ratio of reduced to oxidized glutathione is widely used as an index of oxidative stress (Schafer and Buettner, 2001) , recently the absolute levels of GSSG have been shown to exert significant toxic effects. In fact, the decline in the intracellular levels of GSSG is considered a protective mechanism under conditions of oxidative damage. Therefore, in the current study, the age-dependent reduction in GSH and the further reduction in GSSG are strong indicators of the oxidant environment in the postnatal heart, however, it does not seem that there is an overall increased susceptibility to oxidative stress given the elevated GSH:GSSG ratio. We next examined the levels of various antioxidant enzymes by quantitative mass spectrometry. We found that mitochondrial superoxide dismutase (SOD2) (Halliwell and Gutteridge, 2007) was the only antioxidant enzyme that was significantly increased at P4 and P7 compared to P1, while other antioxidant enzymes failed to increase ( Figure S1E ).
These results led us to hypothesize that oxidative DNA damage caused by ROS may increase in cardiomyocytes postnatally and plays a role in postnatal cell-cycle arrest. Therefore we assessed and quantified oxidative base modification of DNA (8-oxo-7,8-dihydroguanine [8-oxoG] ). We found that nuclear 8-oxoG was undetectable at P1, but significantly increased at P7 and P14 ( Figure 1F , left panels). In concert, DNA damage response pathway was significantly activated as indicated by upregulation of phosphorylated ataxia telangiectasia mutated (pATM), an essential mediator of DNA damage response activation, at P7 and P14 ( Figure 1F , right panels). In addition, further analysis of nuclear 8-oxoG using high resolution confocal microscopy and quantification of oxidized DNA damage foci revealed a significant increase in the number of oxidized DNA damage foci at P4 and P7 compared to P1 ( Figure 1G ). Also, quantitative analysis of nuclear pATM by western blot showed a significant increase in levels as early as P4, with further increase at P7 compared to P1 ( Figure 1G ). Furthermore, qRT-PCR analysis for downstream effectors of the DNA damage response pathway also confirmed upregulation of other DNA damage response components including genes involved in damaged DNA binding and repair ( Figure S1F ). Interestingly, we found that ATM mRNA was mildly downregulated, despite the significant upregulation of the active phosphorylated form of ATM. Moreover, and consistent with our previous findings, 8-oxoG was not detectable in zebrafish cardiomyocytes ( Figure S2 ). These results demonstrate that the increase in mitochondrial respiration corresponds temporally with an increase in ROS in the neonatal heart and activation of DNA damage response.
Environmental Oxygen Regulates Postnatal Cardiomyocyte Cell-Cycle Arrest
To directly test that whether inspired oxygen can influence postnatal cardiomyocyte cell-cycle arrest, we exposed neonates to hyperoxic (100% O 2 ) or mildly hypoxic (15% O 2 ) environment starting at E18.5 (n = 3 each, Figure 2A ). Remarkably, oxidative DNA damage and activation of DDR were accelerated in P4 hyperoxia heart, and in contrast, were repressed in P7 hypoxia heart ( Figure 2B ). We found that heart weight to body weight (HW/BW) ratio was normal in neonates under hyperoxia, but significantly increased in those under hypoxia (Figure 2C ). Cell size quantification showed a significant decrease in cardiomyocyte cell size after hypoxia treatment, although hyperoxic treatment did not change the size ( Figure 2D ). The presence of phosphorylated histone H3 Ser 10 (pH3), a marker of G2-M progression, was significantly decreased in cardiomyocyte after hyperoxia treatment and in contrast increased after hypoxia treatment ( Figure 2E ). In addition, localization of Aurora B kinase at the cleavage furrow, a marker for cytokinesis, was decreased in hyperoxic hearts and mildly increased in hypoxic hearts ( Figure 2F ). These results strongly indicate that postnatal oxygen concentration directly affects cardiomyocyte proliferation.
Reactive Oxygen Species Induce Postnatal Cardiomyocyte Cell-Cycle Arrest To assess the contribution of oxidative stress to cell-cycle arrest of postnatal cardiomyocyte, we injected the ROS generator diquat (5 mg/kg) daily for 3 days after birth (n = 3, Figure 3A) . Strong induction of oxidative DNA damage indicated (E) Coimmunostaining with anti-phosphohistone H3 Ser10 (pH3) and anti-cardiac Troponin T (TnT) antibodies showed drastic decrease in cardiomyocyte mitosis in hyperoxia-exposed hearts, and in contrast, significant increase in cardiomyocyte mitosis in hypoxia-exposed hearts. Cardiomyocyte apoptosis did not increase in either treatment as shown by TUNEL staining. (F) Coimmunostaining with anti-Aurora B and antisarcomeric actinin antibodies showed decreased cytokinesis in hyperoxic hearts, whereas mild increase in hypoxic hearts. Error bars represent SEM. *p < 0.05; **p < 0.01. by 8-oxoG ( Figure 3B ) was observed, and although HW/BW ratio was unchanged ( Figure 3C ), we found that the size of individual cardiomyocytes was significantly increased ( Figure 3D ). In addition, cardiomyocyte mitosis assessed by anti-pH3 staining was drastically reduced in cardiomyocytes in the diquat injected neonates ( Figure 3E ). TUNEL assay showed no increase in apoptotic cell death ( Figure 3E ). Finally, cardiomyocyte cytokinesis assessed by anti-Aurora B staining was also significantly decreased in the hearts of diquat injected neonates ( Figure 3F ). These finding were further confirmed with the injection of another ROS generator paraquat (5 mg/kg, n = 3, Figure S3A) . The injection of paraquat induced an increase in cardiomyocyte cell size ( Figure S3B ) and a decrease in cardiomyocyte mitosis, without significant increase in apoptosis ( Figure S3C ). Cardiomyocyte cytokinesis was consistently decreased with paraquat injection ( Figure S3D ). Moreover, we directly injected 30 ml of 1 mM H 2 O 2 into the apex of P1 mouse hearts (n = 3, Figure S4A ). Two days after H 2 O 2 injection, strong induction of phosphorylated ATM was observed ( Figure S4B ), and although heart weight to body weight ratio was in normal range ( Figure S4C ), the size of individual cardiomyocytes was significantly increased ( Figure S4D ). In addition, cardiomyocyte mitosis was almost completely lost in the H 2 O 2 -treated hearts throughout the entire myocardium ( Figure S4E ). Although a significant increase in apoptotic cardiomyocyte cell death was shown in the direct H 2 O 2 -injected hearts, the vast majority of the TUNEL positive cells were along the needle track, while the effect on myocyte proliferation was global throughout the myocardium ( Figure S4F ). In combination, these results strongly indicate that ROS can induce a shift from hyperplastic to hypertrophic growth in the postnatal mammalian heart. It is important to note here that although there is a clear inhibitory effect on cell-cycle in the absence of increased cell death, the physiological relevance if these stimuli is less certain because we are unable to control the amount or cellular localization of ROS production. 
Scavenging Reactive Oxygen Species Prolongs Postnatal Cardiomyocyte Proliferation
To test whether scavenging ROS can extend cardiomyocyte proliferation after birth, we administered N-acetylcysteine (NAC) daily for 3 weeks after birth (n = 3, Figure 4A ). Staining with dihydrorhodamine 123 showed a decreased cellular ROS level after NAC treatment ( Figure 4B) . Accordingly, the level of 8-oxoG ( Figure 4C ) and phosphorylated ATM ( Figure 4D ) were markedly decreased in cardiomyocyte nuclei after a 1 week treatment with NAC, indicating that oxidative DNA damage and the activation of the DDR by oxidative stress was suppressed. Although HW/BW ratio was normal ( Figure 4E ), cardiomyocyte cell size was significantly decreased in NAC-treated neonates ( Figure 4F ). This suggests that NAC treatment delays the postnatal switch from hyperplastic to hypertrophic growth. To confirm this finding, we performed a number of additional studies. First, we observed that NAC treatment increased the total number of cardiomyocytes ( Figure 4G ). We next examined cardiomyocyte proliferation in NAC-treated hearts. Cardiomyocyte mitosis ( Figure 4H ) in the NAC-treated hearts compared to control hearts at both P7 and P14 ( Figure 4H ) and cytokinesis were significantly increased in the NAC-treated hearts ( Figure 4I ). In addition, we found that the NAC-treated hearts had significantly more mononucleated and less binucleated cardiomyocytes ( Figure 4J ). Finally, TUNEL assay showed no increase in cell death ( Figure 4K ). In addition, NAC treatment on isolated neonatal rat cardiomyocytes significantly increased DNA synthesis and mitosis and also reduced polyploidy ( Figure S5 ). However, we noted that cardiomyocyte proliferation gradually decreased over time in the NAC-treated heart within 1 month after birth (data not shown). Detection of the DHE products with HPLC also indicates that both superoxides and other ROS were significantly reduced upon NAC treatment ( Figure S6A ). qRT-PCR and quantitative mass spectrometry analyses showed little change in levels of proteins involved in oxidative phosphorylation in the NAC-treated p7 hearts compared to control p7 hearts (Figure S6C ). The measurement of NADH oxidase activity revealed increase in mitochondrial respiration at P7 even upon NAC administration ( Figure S6D ). Overall, these results are consistent with a model in which an increase in reactive oxygen species triggers cardiomyocyte cell-cycle arrest shortly after birth.
Mitochondrial-Specific Scavenging of ROS Induces Postnatal Cardiomyocyte Proliferation
To selectively examine whether mitochondrial ROS production is involved in postnatal cell-cycle arrest of cardiomyocytes, we utilized a genetic model to overexpress a radical scavenger specifically in cardiomyocyte mitochondria. We crossed floxed-stop mCAT (mitochondrial-specific catalase) mice, in which floxed transcriptional stop sequences are inserted in between universal GAPDH enhancer/promoter and mCAT (Dai et al., 2011; Schriner et al., 2005) , with Myh6-Cre mice to generate mice expressing mCAT only in cardiomyocytes by cardiomyocyte-specific deletion of floxed-stop with Myh6 enhancer/promoter-driven Cre recombinase (hereinafter called mCAT mice, Figure 5A ). We found that ROS levels were decreased in the mCAT hearts by dihydrorhodamine 123 staining ( Figure 5B ). Quantification of ROS by HPLC detection of EOH peak showed no significant change in the level of superoxide and significant reduction in the E peak, indicative of substantial decrease in H 2 O 2 (as expected given that catalase primarily acts on H 2 O 2 , Figure S6B ). Accordingly, oxidative DNA damage ( Figure 5C ) and the activation of DDR pathway ( Figure S6E ) were suppressed. In mCAT mice, HW/BW ratio was normal ( Figure 5D ), however, cardiomyocyte cell size in mCAT mice at P14 was significantly smaller than that in control mice ( Figure 5E ). In addition, cardiomyocyte mitosis ( Figure 5F ), as well as cytokinesis ( Figure 5G ), were increased in mCAT hearts. Accordingly, the total number of cardiomyocyte in mCAT mice was significantly increased in comparison with that in control mice ( Figure 5H ). The number of proliferative mononucleated cardiomyocytes was increased and binucleated cardiomyocytes were decreased in mCAT heart ( Figure 5I ). Cardiomyocyte apoptosis was in the normal range in mCAT heart ( Figure 5J ). These results indicate that mitochondrial ROS production induces postnatal cell-cycle arrest of cardiomyocytes.
NAC Injection Improves Cardiac Function after Injury
We next tested whether ROS scavenging can extend the regenerative potential of mammalian heart. We injected NAC daily after birth and induced ischemia reperfusion (IR) injury at P21 (n = 12), a time point well beyond the P7 where the postnatal heart loses its regenerative potential ( Figure 6A ). It is important to note here that the control mice also received NAC at the time of IR injury to equalize any effect of NAC injection of ROS-induced infarct expansion following ischemia reperfusion. Cardiomyocyte viability assessed with 2,3,5-trimethyl tetrazolium chloride (TTC) staining was not significantly different between long-term NACtreated and control hearts (n = 3, Figure 6B ). One week and 1 month after the IR injury, there was no significant change in heart size in the NAC-treated animals ( Figure 6C ). WGA staining showed a significant decrease in cardiomyocyte cell size at 1 month after IR injury, which along with the unchanged HW/BW suggests that the NAC-treated hearts have more cardiomyocytes ( Figure 6D ). In addition, systolic function was significantly improved in the NAC-treated group ( Figure 6E ). Fibrotic (legend continued on next page) scar formation was also decreased after NAC treatment (Figure 6F) . Finally, by assessing the number of pH3 positive cardiomyocyte at 3 days after IR ( Figure 6G ) and BrdU incorporation into cardiomyocytes nuclei at 7 days after IR ( Figure 6H ), we showed that cardiomyocyte proliferation was significantly increased in the NAC-treated hearts. These data indicate that scavenging ROS can extend regenerative potential of the heart beyond 1 week after birth. It is important here to note that there may be several effects of NAC going on concomitantly; for example, although we administered NAC to the control group for a short period of time after injury in an attempt counteract any effect of NAC on ROS-mediated reperfusion injury, it is likely that the continued NAC administration over 1 month also resulted in decreased cardiomyocyte loss and remodeling following injury.
Pharmacological Inhibition of DNA Damage Response Pathway Extends the Window of Cardiomyocyte Proliferation in the Postnatal Mouse Heart
In order to determine whether DNA damage-induced activation of cell-cycle checkpoint pathway is involved in cardiomyocytes cell-cycle arrest, we examined the Wee1-dependent activation of G2-M cell-cycle checkpoint in postnatal cardiomyocytes. Activation of ATM or ATR kinase in response to DNA damage in turn activates Wee1 kinase, a repressor of CDK1-dependent G2-M transition ( Figure 7A ) (Heald et al., 1993; Parker and Piwnica-Worms, 1992; Santamaría et al., 2007) . We found that nuclear Wee1 was absent from cardiomyocyte nuclei immediately after birth, but became strongly expressed at P7 as well as P14 ( Figure 7B , left). Western blot confirmed the increased in Wee1 at p4 and further at P7 ( Figure 7B , right). To test whether Wee1 plays a role in postnatal cardiomyocyte cell-cycle arrest, we injected Wee1 inhibitor MK-1775 daily from birth until 2 weeks of age (n = 3, Figure 7C ). Wee1 inhibition resulted in a trend toward decrease in heart size, which was not statistically significant ( Figure 7D ). Notably, Wee1 inhibitor-treated hearts showed robust induction of cardiomyocyte proliferation at P14 indicated by both anti-pH3 ( Figure 7E ) and anti-Aurora B ( Figure 7G ) immunostaining, as well as reduced cardiomyocyte cell size ( Figure 7F ). TUNEL assay showed no increase in apoptotic cell death in Wee1 inhibitortreated hearts ( Figure 7H ). Moreover, total number of cardiomyocytes in Wee1 inhibitor-treated P14 hearts was significantly increased both at P7 and at P14 ( Figure 7I ), and cardiomyocyte binucleation was inhibited ( Figure 7J ). Furthermore, Wee1 was downregulated when ROS was scavenged in NAC injected or mCAT mice ( Figure S6B ) at P7. These results suggest that Wee1 mediates postnatal cardiomyocyte cell-cycle arrest and that blocking Wee1 kinase is sufficient to extend the postnatal proliferative window. In summary, our results indicate that a postnatal increase in mitochondrial-derived reactive oxygen species induces cellcycle arrest through activation of the DNA damage response pathway in mouse heart within 7 days after birth. Moreover, it is intriguing that the oxidation status and regenerative capacity are well correlated among regenerative lower vertebrates and the early postnatal mammalian heart.
DISCUSSION
One of the long-standing mysteries in cardiovascular biology is the permanent cell-cycle arrest of adult cardiomyocytes, both from an etiological as well as mechanistic perspective. From a mechanistic perspective, several regulators of cardiomyocyte cell cycle have been identified (Agah et al., 1997; Bersell et al., 2009; Chen et al., 2013; Eulalio et al., 2012; Jackson et al., 1990; Liao et al., 2001; Liu et al., 2010; Mahmoud et al., 2013; Porrello et al., 2011a; Reiss et al., 1996; Sdek et al., 2011; Xin et al., 2013) including both direct and indirect cellcycle regulators. However, the upstream event that triggers these cascades is unknown. A more important question is why are adult cardiomyocytes unable to re-enter cell cycle on demand, for example after injury? In the current report, we show that the increase in environmental oxygen, and the subsequent upregulation of oxidative metabolism, is the upstream signal that triggers cell-cycle exit of cardiomyocytes shortly after birth.
We provide multiple levels of evidence to support our hypothesis that increased environmental oxygen, with the subsequent increase in mitochondrial oxidative metabolism, induces cardiomyocyte cell-cycle arrest through activation of the DNA damage response. First, we show that the regenerative zebrafish heart, similar to the early postnatal mouse heart, has very low mitochondrial content and complexity, and shows no evidence of activation of the DDR pathway. Second, we show that the postnatal increase in mitochondrial mass, complexity, and activity, increased ROS, increased markers of DNA damage, and activation of DDR pathway, all correlate temporally with cell-cycle exit of cardiomyocytes. Third, we show that postnatal hypoxemia inhibits DNA damage and prolongs the postnatal window of cardiomyocytes proliferation, while postnatal hyperoxemia potentiates DNA damage and early cell-cycle arrest. Fourth, we show that ROS generators induce DDR and early cell-cycle arrest, while both nonspecific and mitochondrial-targeted ROS scavenging delays activation of the DNA damage response and delays cell-cycle arrest of cardiomyocytes. Finally, we show that pharmacological inhibition of the DDR pathway prolongs the postnatal window of cardiomyocyte proliferation. It is important to note here that although we were able to prolong the postnatal window of myocyte proliferation with ROS scavenging, we were unable to prevent cell-cycle arrest. The inevitable cell-cycle exit of cardiomyocyte is likely multifactorial and possibly related to our inability to completely prevent DNA damage, or other factors such as the postnatal change in type and abundance of nutrients (Siggens et al., 2012) or increased hemodynamic stress. Similarly, pharmacological inhibition of Wee1 delayed, but did not prevent, cell-cycle arrest. This is, perhaps, not surprising given the downstream cell-cycle targets of the DDR pathway that do not involve Wee1, which regulates cyclin B/CDK1, while cyclin E/CDK2 is targeted by other components of the DDR pathways. The effect of ROS on cell cycle is complex and probably greatly influenced by level, source, type, compartmentalization, and duration of exposure to ROS. Evidence suggests that ROS can be proproliferative in several scenarios (Leslie, 2006; Tothova et al., 2007) and can stimulate differentiation of several cell types (Lee et al., 2005; Owusu-Ansah and Banerjee, 2009; Tsatmali et al., 2006) including cardiomyocytes. In vitro studies using embryonic stem (ES) cells have shown that redox balance is a critical regulator of cardiomyocyte differentiation (Birket et al., 2013) . ROS mediates mechanical strain and electrical stimulation-induced cardiomyocyte differentiation of ES cells (Pucé at et al., 2003) , while ROS scavengers impair cardiomyocyte formation in embryoid bodies (Pi et (J) Number of binucleated cardiomyocytes was reduced, and mononucleated cardiomyocyte was increased in Wee1 inhibitor-treated heart. Error bars represent SEM. *p < 0.05; **p < 0.01. Yoneyama et al., 2010) . In contrast, ROS-mediated senescence and cell-cycle exit is a well-recognized characteristic of stem cells (Takahashi et al., 2006; Trachootham et al., 2009) . The current report demonstrates that the neonatal mouse heart and the zebrafish heart may have more in common than previously recognized. The hypoxic nature of the zebrafish external and circulatory environments prevents activation of the DDR and cell-cycle arrest of myocytes. In support of this notion, additional hypoxia actually enhances myocyte proliferation and regenerative capacity of zebrafish hearts (Jopling et al., 2012; Marques et al., 2008) and in the current report, prolongs the postnatal window of myocyte proliferation in mammals. Shortly after birth, the metabolic switch that occurs in the mammalian heart confers significant energy efficiency through oxidative metabolism, unfortunately at the expense of proliferative competency. We conclude that mitochondrial ROS-mediated activation of the DDR is an important upstream event that mediates cell-cycle arrest of postnatal cardiomyocytes.
EXPERIMENTAL PROCEDURES
Animal Breeding and Genotyping All protocols were approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center (UTSW). All experiments were performed on age-and sex-matched mice, with equal ratio of male to female mice. The number of animals used for each experiment; n = 3. Transgenic mCAT mice were kindly provided by Dr. Ravinovitch. Mice were genotyped as described previously (Dai et al., 2011; Schriner et al., 2005) .
Drug Injection
N-acetyl-L-cysteine (NAC, Sigma) was reconstituted in PBS to concentrations of 10 mg/ml. CD-1 (Charles River) mice were weighed daily and 75 mg/kg of NAC was injected daily subcutaneously or intraperitoneal from day 0 to day 14. Wee1-inhibitors (MK-1775, Selleck) were reconstituted in diluted DMSO. CD-1 mice were injected daily with 2.5 mg/kg subcutaneously or intraperitoneal from day 0 to day 14. Diquat, paraquat, and H 2 O 2 were diluted in PBS and injected into CD-1 neonates as described in Results.
Histology
Hearts were harvested and fixed in 4% paraformaldehyde (PFA)/PBS solution overnight at room temperature and then processed for paraffin sectioning. Masson's trichrome staining was performed according to standard procedures at UTSW core histology facility on paraffin sections. TUNEL staining was performed according to manufacturer's recommendations (In Situ Cell Death Detection Kit, Fluorescein, catalog number 11684795910, Roche).
Immunostaining
Following antigen retrieval with 1 mM EDTA in boiling water, sections were blocked with 10% serum from host animal of secondary antibodies, and incubated with primary antibodies overnight at 4 C. Sections were subsequently washed with PBS and incubated with corresponding secondary antibodies conjugated to Alexa Fluor 350, 488, or 555 (Invitrogen). Primary antibodies used are following: anti-phospho Histone H3 Ser10 (Millipore 06-570, 1:100), anti-Aurora B (Sigma A5102, 1:100), anti-Troponin T, Cardiac Isoform Ab-1, Clone 13-11 (Thermo Scientific MS-295-P1, 1:100), anti-Bromodeoxyuridine (Roche 11170376001, 1:25), anti-Sarcomeric Alpha Actinin (Abcam, ab68167, 1:100), anti-Oxoguanine 8 (Abcam Ab64548, 1:100), anti-phosphorylated ATM (Santa Cruz Biotechnology sc-47739, 1:100), anti-Wee1 (Abcam ab137377, 1:100), and anti-wheat germ agglutinin (WGA) conjugated to Alexa Fluor 488 (50 mg/ml, Invitrogen).
Cardiomyocyte Isolation
The isolation of cardiomyocyte from neonatal hearts and staining with anticonnexin 43 antibody were performed as previously described .
Reactive Oxygen Species Determination
Dihydrorhodamine 123 (Life Technologies, D-23806) or CM-H2DCFDA (Life Technologies, C6827) and HPLC detection of DHE were used to detect ROS. See Extended Experimental Procedures for detailed methods.
Cristae Measurement
Spacings between cristae in individual mitochondria were quantified using ImageJ. Only mitochondria with several well-defined, parallel cristae were selected for analysis. The ImageJ line tool was used to draw a line across the stack of cristae, perpendicular to the orientation of the cristae, and the number of cristae crossing the line was counted interactively. The pixel size defined in the image metadata was used to obtain the length of the line profile in mm.
Western Blotting
Western blot was performed using standard protocols. See Extended Experimental Procedures for detailed methods.
Statistical Analysis
One-tailed or two-tailed Student's t test was used to determine statistical significance and *p < 0.05 and **p < 0.01 was considered statistically different. All quantification is blinded.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six figures, and one table and can be found with this article online at http://dx. doi.org/10.1016/j.cell.2014.03.032.
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